Showing results (861-870 of 6,955) with videos related to

Sort By:
Pageof 696
Journal of Clinical Pharmacology|October 22, 2004
Induction of CYP3A4 by efavirenz in primary human hepatocytes: comparison with rifampin and phenobarbitalNiresh Hariparsad, Srikanth C Nallani, Rucha S Sane, et al.
Journal of Clinical Pharmacology|October 22, 2004
Pharmacokinetic and pharmacodynamic analysis of amprenavir-containing combination therapy in HIV-1-infected childrenDaniel S Stein, Yu Lou, Mark Johnson, et al.
Journal of Clinical Pharmacology|December 17, 2004
Intraindividual and interindividual variations in the pharmacokinetics of mycophenolic acid in liver transplant patientsJaya Pisupati, Ashok Jain, Gilbert Burckart, et al.
Journal of Clinical Pharmacology|December 17, 2004
The pharmacokinetics of daptomycin in moderately obese, morbidly obese, and matched nonobese subjectsBarry H Dvorchik, David Damphousse
Journal of Clinical Pharmacology|December 17, 2004
Impulsive-aggressive traits, serotonin function, and alcohol-enhanced aggressionCarl Fulwiler, Joy Eckstine, Sapna Kalsy
Journal of Clinical Pharmacology|February 11, 2005
Population pharmacokinetics of motexafin gadolinium in adults with brain metastases or glioblastoma multiformeDale R Miles, Jennifer A Smith, See-Chun Phan, et al.
Journal of Clinical Pharmacology|February 24, 2006
Pharmacokinetics of aprepitant after single and multiple oral doses in healthy volunteersAnup K Majumdar, Laura Howard, Michael R Goldberg, et al.
Journal of Clinical Pharmacology|February 24, 2006
Single- and multiple-dose pharmacokinetics of dapoxetine hydrochloride, a novel agent for the treatment of premature ejaculationNishit B Modi, Mark J Dresser, Mary Simon, et al.
Journal of Clinical Pharmacology|February 24, 2006
Use of omeprazole as a CYP3A probe drug: effect of sex and menstrual cycle phase on CYP3A activity in healthy Caucasian adultsYanhua Zhang, Myong-Jin Kim, Joseph S Bertino, et al.
Pageof 696